Citi Starts Crinetics (CRNX) at Buy, Opens 30-Day Upside Catalyst Watch, 'Upcoming Paltusotine Catalysts Primed to Drive Upside'
Tweet Send to a Friend
(Updated - March 6, 2024 3:59 AM EST)
Citi analyst David Lebowitz initiates coverage on Crinetics (NASDAQ: CRNX) with ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
Citi analyst David Lebowitz initiates coverage on Crinetics (NASDAQ: CRNX) with ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
